From the parathyroid to adrenal glands and thyroid tumors, the latest WHO classification introduces essential updates to tumor nomenclature and diagnostic criteria.
A groundbreaking late-stage study highlights the effectiveness of Viridian Therapeutics' novel treatment, veligrotug, for chronic thyroid eye disease, offering hope for more convenient and efficient therapy. Positive results led to a substantial boost in the company's stock price.
The FDA has approved crinecerfont (Crenessity) to manage androgen levels in classic congenital adrenal hyperplasia in individuals aged 4 or older. Find out more at FDA.
Data revealed that levothyroxine users experienced greater bone loss even with normal TSH levels, prompting researchers to question current treatment guidelines for the second most prescribed medication among older adults.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
New study reveals that epigenetic age predictions fluctuate significantly throughout the day, emphasizing the need to consider timing in aging assessments.
Explore new techniques in corneal transplantation, including Descemet’s membrane endothelial keratoplasty and artificial corneas, for treating corneal diseases.
A recent study found that extreme Body Roundness Index levels significantly increase the risk of all-cause mortality among US adults, highlighting the importance of this measure in health assessments.